Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1999
10/21/1999WO1999053049A1 Epitope-driven human antibody production and gene expression profiling
10/21/1999WO1999053048A1 DNA SEQUENCE IN THE Sp5 MUTANT AND SITE SPECIFIC GENETIC RECOMBINATION
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053046A2 Noncloning technique for expressing a gene of interest
10/21/1999WO1999053044A2 High throughput dna sequencing vector
10/21/1999WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999WO1999053042A2 Biological material with increased expression of endogenous complement regulatory molecules
10/21/1999WO1999053041A2 Method for increasing vitamin c content of plants
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053038A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/21/1999WO1999053037A2 Optimized nucleotide sequence encoding organophosphorous hydrolase and methods of use for same
10/21/1999WO1999053036A2 Ste20-related protein kinases
10/21/1999WO1999053035A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells
10/21/1999WO1999053034A1 Improved live attenuated viruses for use as vectors or vaccines
10/21/1999WO1999053033A1 Methods and compositions for high yield production of eukaryotic proteins
10/21/1999WO1999053032A1 TRANSGENIC MAMMALS EXPRESSING MUTANT GP IIIa
10/21/1999WO1999053031A2 Process for producing cell clone libraries
10/21/1999WO1999053028A1 Pns cell lines and methods of use therefor
10/21/1999WO1999053025A1 Method of nuclear transfer
10/21/1999WO1999053021A1 Cell differentiation/proliferation and maintenance factor and uses thereof
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999053018A2 Purification of cellular components that are substantially rna free
10/21/1999WO1999053017A2 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
10/21/1999WO1999053016A2 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052944A1 G-protein coupled receptors
10/21/1999WO1999052943A1 T cell receptor expression cassette
10/21/1999WO1999052942A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
10/21/1999WO1999052939A1 Peptides
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052927A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999WO1999052926A1 Regulated target expression for screening
10/21/1999WO1999052925A1 Programmed cell death and caspase-12
10/21/1999WO1999052924A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999WO1999052563A1 A method for the targeting of proteins produced by yersinia into the cytosol of eukaryotic cells
10/21/1999WO1999052548A2 Conjugate vaccines for the prevention of dental caries
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052540A1 Methods for treatment and prevention of infections
10/21/1999WO1999052463A1 Needleless administration of polynucleotide formulations
10/21/1999WO1999052415A2 Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor
10/21/1999WO1999052349A1 Hiv transgenic animals and uses therefor
10/21/1999WO1999047654A3 Combination of genes for regulating flowering induction in useful and ornamental plants
10/21/1999WO1999047102A3 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/21/1999WO1999046396A3 Glyphosate as a gametocide
10/21/1999WO1999046391A3 Prostate derived serine protease (pdsp) protein and nucleic acid molecules and uses therefor
10/21/1999WO1999046386B1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999045143A3 A fluorescence polarization screening method
10/21/1999WO1999045119A3 Production of mycobacterial polypeptides by lactic acid bacteria
10/21/1999WO1999042598A3 Hybrid seed production
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042577A3 Biotin-binding receptor molecules
10/21/1999WO1999042474A3 Method for designing dna-binding proteins of the zinc-finger class
10/21/1999WO1999042137A3 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999041415A9 Transposable element-anchored, amplification method for isolation and identification of tagged genes
10/21/1999WO1999040213A9 Genetic manipulation of spermatogonia
10/21/1999WO1999040114A9 Novel gabab receptor dna sequences
10/21/1999WO1999038988A3 A chemical inducible promoter used to obtain transgenic plants with a silent marker
10/21/1999WO1999038980A9 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
10/21/1999WO1999037794A8 Methods and composition for modulating flavonoid content
10/21/1999WO1999036571A3 Method for the detection or nucleic acid of nucleic acid sequences
10/21/1999WO1999036553A3 Regulation of biological events using multimeric chimeric proteins
10/21/1999WO1999036530A3 Lh-receptor gene promoter for tissue-specific gene expression
10/21/1999WO1999036529A3 Twik-1 related two p domains potassium channel
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999032643A3 Mood disorder gene
10/21/1999WO1999030157A9 Neuropilins in methods for diagnosis and prognosis of cancer
10/21/1999WO1999029905B1 Method for detecting apoptosis using fret labeled oligonucleotides
10/21/1999WO1999024607A3 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI)
10/21/1999WO1999019472A9 Vectors comprising a magnum-specific promoter for avian transgenesis
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999WO1998041625A8 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
10/21/1999DE19826758C1 Production of closed, double-stranded DNA molecules for use in gene therapy or genetic vaccination
10/21/1999DE19818598A1 New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents
10/21/1999DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817921A1 New mycobacterial mutants used to screen for antibiotic vectors
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19816496A1 New catalytically active subunit of human telomerase
10/21/1999DE19814853A1 Expressionssystem zur Produktion von Proteinen Expression system for production of proteins
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999DE19741375C2 Transgene Pflanzen, deren oberirdische Teile früher reifen und vollständig absterben Transgenic plants ripen their aerial parts earlier and completely die
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2736981A1 Process for producing isoprenoid compounds by microorganisms
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2402599A1 Programmed cell death and caspase-12
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2328719A1 Method for in vivo detecting target protein gene by drug
10/21/1999CA2328461A1 Flowering locus t (ft) and genetically modified plants having modulated flower development
10/21/1999CA2328298A1 Method for electroelution of a biological sample and implementing device
10/21/1999CA2328180A1 Needleless administration of polynucleotide formulations
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2327830A1 Methods for identifying genetic determinants associated with modulation of test compound activity
10/21/1999CA2327516A1 Programmed cell death and caspase-12
10/21/1999CA2326847A1 Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus
10/21/1999CA2326687A1 Interconversion of plant fatty acid desaturases and hydroxylases
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325817A1 Transgenic mammals expressing mutant gp iiia
1 ... 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 ... 4023